Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristoforo Silvestri

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|August 27, 2019
Role of the Endocannabinoidome in Human and Mouse AtherosclerosisFabiana Piscitelli, Cristoforo Silvestri
Expert Opinion on Investigational Drugs|July 12, 2012
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disordersCristoforo Silvestri, Vincenzo Di Marzo
Cell Metabolism|April 9, 2013
The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disordersCristoforo Silvestri, Vincenzo Di Marzo
Nutrients|August 23, 2019
Lifestyle and Metabolic Syndrome: Contribution of the EndocannabinoidomeVincenzo Di Marzo, Cristoforo Silvestri
Reviews in Endocrine & Metabolic Disorders|February 22, 2011
Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscleCristoforo Silvestri, Alessia Ligresti, Vincenzo Di Marzo
Current Diabetes Reports|November 6, 2019
The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes MellitusAlain Veilleux, Vincenzo Di Marzo, Cristoforo Silvestri
Cells|June 24, 2022
Obesity: The Fat Tissue Disease Version of CancerBesma Boubertakh, Cristoforo Silvestri, Vincenzo Di Marzo
Journal of Lipid Research|September 20, 2023
New role for the anandamide metabolite prostaglandin F<sub>2α</sub> ethanolamide: Rolling preadipocyte proliferationBesma Boubertakh, Olivier Courtemanche, David Marsolais, et al.
Plos One|February 23, 2026
Understanding the gut microbiome through a fitness intervention of aerobic and resistance training for individuals with type 2 diabetes mellitus (GUTFIT: A Study Protocol)Amy M Thomson, Dominique C Drost, Neil M Johannsen, et al.
Pharmacological Research|September 1, 2018
Δ<sup>9</sup>-tetrahydrocannabivarin impairs epithelial calcium transport through inhibition of TRPV5 and TRPV6Annelies Janssens, Cristoforo Silvestri, Andrea Martella, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|August 27, 2019
Role of the Endocannabinoidome in Human and Mouse AtherosclerosisFabiana Piscitelli, Cristoforo Silvestri
Expert Opinion on Investigational Drugs|July 12, 2012
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disordersCristoforo Silvestri, Vincenzo Di Marzo
Cell Metabolism|April 9, 2013
The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disordersCristoforo Silvestri, Vincenzo Di Marzo
Nutrients|August 23, 2019
Lifestyle and Metabolic Syndrome: Contribution of the EndocannabinoidomeVincenzo Di Marzo, Cristoforo Silvestri
Reviews in Endocrine & Metabolic Disorders|February 22, 2011
Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscleCristoforo Silvestri, Alessia Ligresti, Vincenzo Di Marzo
Current Diabetes Reports|November 6, 2019
The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes MellitusAlain Veilleux, Vincenzo Di Marzo, Cristoforo Silvestri
Cells|June 24, 2022
Obesity: The Fat Tissue Disease Version of CancerBesma Boubertakh, Cristoforo Silvestri, Vincenzo Di Marzo
Journal of Lipid Research|September 20, 2023
New role for the anandamide metabolite prostaglandin F<sub>2α</sub> ethanolamide: Rolling preadipocyte proliferationBesma Boubertakh, Olivier Courtemanche, David Marsolais, et al.
Plos One|February 23, 2026
Understanding the gut microbiome through a fitness intervention of aerobic and resistance training for individuals with type 2 diabetes mellitus (GUTFIT: A Study Protocol)Amy M Thomson, Dominique C Drost, Neil M Johannsen, et al.
Pharmacological Research|September 1, 2018
Δ<sup>9</sup>-tetrahydrocannabivarin impairs epithelial calcium transport through inhibition of TRPV5 and TRPV6Annelies Janssens, Cristoforo Silvestri, Andrea Martella, et al.
Pageof 7